-
Sector Analysis
Head and Neck Cancers: Epidemiology Forecast to 2026
Head and neck cancers usually begin in the squamous cells that line the moist mucosal surfaces of the tissues and organs of the head and neck—more than 83% of all oral cavity and pharynx cancers are squamous cell carcinomas. They are the ninth most common malignancy in the world, with high mortality rates in the developing countries 10-year epidemiological forecasts of the diagnosed incident cases of HNCs are provided. HNCs are grouped into the following, in this report: 1. Cancers...
-
Product Insights
Neoplastic Syndrome Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neoplastic Syndrome Global Clinical Trials Review, H1, 2018" provides an overview of Neoplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Neoplastic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Neuroblastoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Neuroblastoma Clinical Trials Market Report Overview There were a total of 680 neuroblastoma clinical trials conducted as of January 2023. The neuroblastoma clinical trial market research report provides a comprehensive overview of the market across regions and countries (G7 & E7). It also provides insights into the various phases, trial status, and end points status. The report includes information about the sponsor types and the prominent sponsors associated with the trials as well. Neuroblastoma Clinical Trials Market Segmentation by Regions...
-
Product Insights
Neuroendocrine Cancer Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neuroendocrine Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Neuroendocrine Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Neuroendocrine Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2018" provides an overview of Neuroendocrine Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Neuroendocrine Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2018" provides an overview of Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Nonseminomatous Testicular Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Nonseminomatous Testicular Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Small Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
COETrendSights - Health & Wellness - INDUI290623T1
"TrendSights - Health & Wellness: 'Better for You' Alcoholic Drinks" is part of GlobalData's TrendSights series. The concept of "better for you" alcoholic drinks strongly links to GlobalData's Health & Wellness consumer trend. This report outlines the healthier alcoholic beverage innovation movement driven by consumers' concerns around alcohol consumption and pursuit of healthier lifestyles. To meet these consumer demands, producers are incorporating "better for you" ingredients like fruit juice, water, and tea. They are also catering to consumer demand for...
-
Sector Analysis
Acute Lymphocytic Leukemia (ALL) - Cell Therapies 15-Market Assessment and Sales Forecast to 2031
Acute Lymphocytic Leukemia Cell Therapy Market Overview The total market value for the 15M, which includes both cell therapies and established/traditional ALL therapies was $2.3 billion in 2021. The need for “off-the-shelf” products with lower costs and reduced infrastructure requirements raises the development of allogeneic agents thereby driving the market growth. Acute Lymphocytic Leukemia (ALL) – Cell Therapies 15-Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the Acute Lymphocytic Leukemia (ALL) – Cell Therapies 15-Market...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.